Welcome to our dedicated page for AMETEK INC/ SEC filings (Ticker: AME), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMETEK INC/'s stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMETEK INC/'s regulatory disclosures and financial reporting.
AMETEK (AME) insider transaction: The company’s Chief Administrative Officer reported option exercises and an open‑market sale on 10/31/2025. He exercised 14,310 options at $63.37 and 11,980 options at $85.45, then sold 26,290 shares at an average price of $200.0459, per the filing.
Following these transactions, beneficial ownership stood at 40,226 shares held directly, 910 shares held indirectly via a 401(k) plan, and 4,865 shares shown as direct under a SERP-related line item. The sale price range was $200.00 to $200.19, with details available upon request.
AMETEK (AME) filed a Form 144 notice for a proposed sale of 26,290 shares of common stock. The filing lists an aggregate market value of $5,259,208.00, with sales expected around 10/31/2025 on the NYSE. The designated broker is Charles Schwab & Co., Inc.
The shares were acquired via an employee stock option exercise on 10/31/2025 through a broker payment for cashless exercise. Shares outstanding were 230,203,873. Form 144 is a notice of intent under Rule 144 and does not itself constitute a registration or sale.
AMETEK (AME) reported record Q3 2025 results, with net sales of $1,892.6 million, up 10.8% year over year. Operating income reached $488.4 million and diluted EPS rose to $1.60, up 8.8%. Net income was $371.4 million. Orders were a record $1,967.8 million and backlog stood at a record $3,546.3 million.
Segment performance was solid. EIG sales increased to $1,246.3 million, aided by acquisitions, while EMG sales grew to $646.3 million on 12% organic growth. Reported margins reflected acquisition mix and one‑time costs; excluding these effects, margins expanded on Operational Excellence benefits.
Year to date, net sales were $5,402.7 million and operating income was $1,404.8 million. The company closed FARO and Kern, deploying $933.2 million in cash, and ended the quarter with $439.2 million in cash and $2,464.2 million in total debt, including $635.0 million outstanding under the commercial paper program. Free cash flow was $1,144.2 million for the first nine months, and the quarterly dividend was raised to $0.31 per share.
AMETEK, Inc. (AME) furnished an Item 2.02 Form 8-K announcing quarterly results. The company provided a press release for the three and nine months ended September 30, 2025, furnished as Exhibit 99.1. The release is titled “AMETEK Announces Record Third Quarter Results and Raises Full Year Guidance,” indicating strong performance and an updated outlook. The press release is dated October 30, 2025 and is incorporated by reference. The information was furnished, not filed, under the Exchange Act.
John Wesley Hardin, an officer (President - Electronic Instruments) of AMETEK Inc. (AME), reported transactions on Form 4. On 09/11/2025 he sold 7,867 shares of AMETEK common stock at prices ranging from $188.00 to $188.24, leaving 65,235 shares directly beneficially owned. On 09/12/2025 he recorded dividend reinvestments: 80 shares credited to a Supplemental Executive Retirement Plan (SERP) increasing that holding to 23,084 shares (direct) and 2 shares credited to the AMETEK 401(k) Plan reported as 525 shares (indirect). The form was signed by an attorney-in-fact on 09/12/2025. The filing includes an offer to provide per-price lot details to the SEC staff on request.
Form 144 notice for AMETEK, Inc. (AME) reports a proposed sale of 7,867 common shares through Charles Schwab & Co., Inc., with an aggregate market value of $1,479,209.00 and approximately 230,953,960 shares outstanding. The proposed approximate sale date is 09/11/2025 on the NYSE.
The shares were acquired on 02/22/2024 as equity compensation (RSU/PSU) from AMETEK, Inc. The filer states there were no securities sold in the past three months for the account and includes the standard representation that the seller is not aware of undisclosed material adverse information.
David A. Zapico, identified as both a director and the Chief Executive Officer of AMETEK, reported changes in his beneficial ownership of AME common stock. The filing discloses a dividend reinvestment under the Supplemental Executive Retirement Plan (SERP) for 210 shares at no cash price and a disposition of 35,973 shares at $186.95 per share. The report lists post-transaction holdings tied to those entries and the broader common stock position as shown in the form.
The document provides transaction codes and ownership form designations and is signed by an attorney-in-fact on behalf of Mr. Zapico. The filing does not include commentary or explanations beyond a note that the 210-share acquisition represents dividend reinvestment pursuant to the SERP.